ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

RTOG Finds Twice A Day Radiation For Advanced Head And Neck Cancer Improved Local Tumor Control Rate

August 25, 2000

Four CIDAC Contracts Will Go To Cancer Research Centers; RFPs To Be Released January or February

December 20, 1974

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993

Radiation To Stem Cell Niche Improved PFS In Glioblastoma

August 27, 2010

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992